Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the 14-day and 12-week safety and efficacy of Depakote
ER used in combination with either olanzapine or risperidone versus antipsychotic monotherapy
with olanzapine or risperidone for the treatment of schizophrenia.